Lidocaine 50 MG/ML Topical Cream — RxCUI 1534792
RxNorm drug concept · Semantic clinical drug
RxCUI 1534792
Semantic clinical drug · SCD
● Current RxNorm concept 20 FDA products
29 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1534792
Official nameLidocaine 50 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslidocaine 5 % Topical Cream
FDA products mapped20
Package NDCs mapped29
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- This patch is used to treat post-herpetic neuralgia — that's the persistent burning or aching nerve pain that sometimes sticks around after a shingles outbreak, even after the rash...
- What is this patch actually for — why did my doctor prescribe it?
- You wear it for up to 12 hours, then take it off for the next 12 hours — think of it as '12 hours on, 12 hours off.' Your prescriber may allow up to 3 patches at a time, but never...
- How long do I wear the patch, and can I wear more than one?
🕸️ Concept Web — How Lidocaine 50 MG/ML Topical Cream Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Lidocaine 50 MG/ML Topical Cream
RxCUI 1534792 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Lidocaine
6387IN
-
Lidocaine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Lipocaine
2120171BN
-
Lipocaine
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Lidocaine Topical Cream
377740SCDF -
Lidocaine Topical Product
1164666SCDG -
Lidocaine Topical Cream [Lipocaine]
2120173SBDF -
Lipocaine Topical Product
2120174SBDG -
Topical Cream
316982DF -
Topical Product
1151122DFG
-
Lidocaine Topical Cream
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Lidocaine 50 MG/ML
329928SCDC -
Lidocaine 50 MG/ML Topical Cream [Lipocaine]
2120175SBD -
Lidocaine 50 MG/ML [Lipocaine]
2120172SBDC
-
Lidocaine 50 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Lidocaine 50 MG/ML
SCDC · 329928 -
Lidocaine Topical Cream
SCDF · 377740 -
Lidocaine Topical Product
SCDG · 1164666
Brand-Name Concepts
-
Lidocaine 50 MG/ML Topical Cream [Lipocaine]
SBD · 2120175 -
Lidocaine 50 MG/ML [Lipocaine]
SBDC · 2120172 -
Lidocaine Topical Cream [Lipocaine]
SBDF · 2120173 -
Lipocaine Topical Product
SBDG · 2120174 -
Lipocaine
BN · 2120171
📦 FDA Products & Package NDCs
20 products · 29 package NDCs
29 package NDCs map to RxCUI 1534792 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 58980-0823-05 | 1 TUBE in 1 BOX (58980-823-05) / 14.17 g in 1 TUBE | LIDOCAINE | STRATUS PHARMACEUTICALS INC | 2023-12-18 |
| 58980-0823-30 | 1 TUBE in 1 BOX (58980-823-30) / 28.35 g in 1 TUBE | LIDOCAINE | STRATUS PHARMACEUTICALS INC | 2019-08-12 |
| 60771-0011-01 | 44 mL in 1 BOTTLE (60771-0011-1) | Adellina Numbing Cream | Guangzhou Haishi Biological Technology Co., Ltd. | 2025-03-27 |
| 63135-0811-04 | 113 g in 1 TUBE (63135-811-04) | LIPOCAINE 5 | ESBA LABORATORIES INC. | 2019-03-18 |
| 63135-0811-30 | 1 TUBE in 1 CARTON (63135-811-30) / 30 g in 1 TUBE | LIPOCAINE 5 | ESBA LABORATORIES INC. | 2019-03-18 |
| 67194-0022-01 | 15 g in 1 JAR (67194-022-01) | Microcaine Topical Analgesic | Unit Dose, Ltd. | 2016-01-19 |
| 73287-0026-01 | 1 JAR in 1 CARTON (73287-026-01) / 85 g in 1 JAR | Hempvana Maximum Strength Pain Relief Topical Anesthetic | Telebrands Corp | 2023-02-17 |
| 73581-0022-06 | 170 mL in 1 JAR (73581-022-06) | Lidocaine | YYBA Corp | 2026-04-01 |
| 73581-0105-01 | 30 mL in 1 TUBE (73581-105-01) | Lidocaine Numbing Cream | Yyba Corp | 2023-12-11 |
| 73581-0105-02 | 60 mL in 1 TUBE (73581-105-02) | Lidocaine Numbing Cream | Yyba Corp | 2023-12-11 |
| 73581-0105-04 | 113 mL in 1 JAR (73581-105-04) | Lidocaine Numbing Cream | YYBA Corp | 2020-11-13 |
| 73581-0105-55 | 156 mL in 1 JAR (73581-105-55) | Lidocaine Numbing Cream | Yyba Corp | 2022-06-17 |
| 73581-0114-01 | 30 mL in 1 TUBE (73581-114-01) | Lidocaine | YYBA Corp | 2025-12-01 |
| 73581-0114-02 | 60 mL in 1 TUBE (73581-114-02) | Lidocaine | YYBA Corp | 2025-12-01 |
| 73581-0114-06 | 170 mL in 1 JAR (73581-114-06) | Lidocaine | YYBA Corp | 2025-12-01 |
| 82929-0011-01 | 1 BOTTLE in 1 BOX (82929-011-01) / 60 mL in 1 BOTTLE | Numbing Cream | Sainite Trading Shenzhen Co., Ltd. | 2026-02-04 |
| 83364-0024-01 | 1 BOTTLE in 1 BOX (83364-024-01) / 60 g in 1 BOTTLE | Healcome Lidocaine Numbing Cream | YITONGBADA (SHENZHEN) INTERNATIONAL TRADE CO., LTD | 2026-05-12 |
| 83887-0008-01 | 60 g in 1 BOTTLE (83887-008-01) | Pressy Tattoo Numbing Cream | Changsha Beiliang E-commerce Co., Ltd | 2025-06-12 |
| 83887-0009-01 | 60 mL in 1 TUBE (83887-009-01) | Tattoo Numbing Cream | Changsha Beiliang E-commerce Co., Ltd | 2025-06-12 |
| 84007-0335-01 | 30 g in 1 CARTON (84007-335-01) | LIDOCAINE 5% | Medhome Pharma Inc | 2025-12-23 |
| 84019-0043-01 | 30 g in 1 BOTTLE (84019-043-01) | Signature Lidocaine Pain Relief Cream | Shengnan (Guangzhou) Cosmetics Co., LTD | 2026-03-06 |
| 84546-0010-01 | 1 TUBE in 1 CARTON (84546-0010-1) / 30 g in 1 TUBE | ElixirLidoFast | ELIXIR HEALTHCARE USA, LLC. | 2025-12-01 |
| 84546-0010-02 | 1 TUBE in 1 CARTON (84546-0010-2) / 60 g in 1 TUBE | ElixirLidoFast | ELIXIR HEALTHCARE USA, LLC. | 2025-12-01 |
| 84546-0010-03 | 142 g in 1 JAR (84546-0010-3) | ElixirLidoFast | ELIXIR HEALTHCARE USA, LLC. | 2025-12-01 |
| 84546-0010-04 | 156 g in 1 JAR (84546-0010-4) | ElixirLidoFast | ELIXIR HEALTHCARE USA, LLC. | 2025-12-01 |
| 85150-0004-01 | 50 g in 1 BOTTLE (85150-004-01) | VTROUY Tattoo Numbing Cream | Guangzhou Zanming Trading Co., Ltd. | 2025-02-20 |
| 85248-0177-01 | 50 g in 1 BOTTLE (85248-177-01) | DR.PABU NUMBING | Jiangxi Yudexi Pharmaceutical Co., LTD | 2026-03-30 |
| 85342-0002-01 | 60 g in 1 BOTTLE, GLASS (85342-002-01) | Tattoo numbing | Guangzhou Sanshisan Cosmetics Co., Ltd. | 2025-04-21 |
| 87408-0021-01 | 1 BOTTLE in 1 CARTON (87408-021-01) / 60 g in 1 BOTTLE | Arlun LIDOCAINE Cream | Guangzhou Jingliang Cosmetics Co., Ltd. | 2026-05-20 |
Observed labelers:
YYBA Corp (8) ·
ELIXIR HEALTHCARE USA, LLC. (4) ·
Changsha Beiliang E-commerce Co., Ltd (2) ·
ESBA LABORATORIES INC. (2) ·
STRATUS PHARMACEUTICALS INC (2) ·
Guangzhou Haishi Biological Technology Co., Ltd. (1)
· +10 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.